Evidence map›Paper›PMID 35501860›Full record

ArticleBMC medical genomics2022

A systematic analysis of gene-gene interaction in multiple sclerosis.

Lotfi Slim, Clément Chatelain, Hélène de Foucauld, Chloé-Agathe Azencott

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Heterogeneous network approaches to protein pathway prediction.Computational and structural biotechnology journal · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lotfi SlimCBIO, MINES ParisTech, PSL Research University, 75006, Paris, France. lslim@nvidia.com.
Clément ChatelainTranslational Sciences, SANOFI R&D, 91385, Chilly-Mazarin, France.
Hélène de FoucauldTranslational Sciences, SANOFI R&D, 91385, Chilly-Mazarin, France.
Chloé-Agathe AzencottCBIO, MINES ParisTech, PSL Research University, 75006, Paris, France.
Sanofi (France) · FRUniversité Paris Sciences et Lettres · FR

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundFor the most part, genome-wide association studies (GWAS) have only partially explained the heritability of complex diseases. One of their limitations is to assume independent contributions of individual variants to the phenotype. Many tools have therefore been developed to investigate the interactions between distant loci, or epistasis. Among them, the recently proposed EpiGWAS models the interactions between a target variant and the rest of the genome. However, applying this approach to studying interactions along all genes of a disease map is not straightforward. Here, we propose a pipeline to that effect, which we illustrate by investigating a multiple sclerosis GWAS dataset from the Wellcome Trust Case Control Consortium 2 through 19 disease maps from the MetaCore pathway database.

resultsFor each disease map, we build an epistatic network by connecting the genes that are deemed to interact. These networks tend to be connected, complementary to the disease maps and contain hubs. In addition, we report 4 epistatic gene pairs involving missense variants, and 25 gene pairs with a deleterious epistatic effect mediated by eQTLs. Among these, we highlight the interaction of GLI-1 and SUFU, and of IP10 and NF-[Formula: see text]B, as they both match known biological interactions. The latter pair is particularly promising for therapeutic development, as both genes have known inhibitors.

conclusionsOur study showcases the ability of EpiGWAS to uncover biologically interpretable epistatic interactions that are potentially actionable for the development of combination therapy.

Indexed as

Epistasis, GeneticMultiple SclerosisCase-Control StudiesGenome-Wide Association StudyHumansPhenotypeCausal inferenceEpistasisGene–gene interactionGWASMultiple sclerosis

Identifiers

PMID35501860
PMCPMC9063218
OpenAlexW4225270108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.